AM Best has removed from under review with negative implications and affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings of “a-” (Excellent) of Pharmacists Mutual Insurance Company (PMIC) and its wholly owned reinsured subsidiary, Chiron Insurance Company (Chiron). Concurrently, AM Best has removed from under review with negative implications and affirmed the Long-Term Issue Credit Rating of “bbb” (Good) on the $25 million, 7.375% surplus notes, due 2039, issued by PMIC. These companies are domiciled in Algona, IA and collectively referred to as Pharmacists Mutual Insurance Group (PMIG). The outlook assigned to these Credit Ratings (ratings) is negative.

The ratings reflect PMIG’s balance sheet strength, which AM Best assesses as very strong, as well as its marginal operating performance, neutral business profile and appropriate enterprise risk management.

The ratings were initially placed under review with negative implications in March of 2024, following substantial weakening in PMIG’s key balance sheet strength metrics and its policyholders’ surplus, as well as management’s intent to address these issues through various capital management strategies. Effective June 1, 2024, PMIG pursued one of these initiatives and entered into a multiple-line quota share reinsurance agreement, which provides for 45% cession of all in-force policies (excluding umbrella, equipment breakdown, cyber, EPLI and SAM) and effectively reduces its retention on individual losses from $1 million to $550,000. Participation in this agreement provided immediate capital relief of nearly $9 million. Due to the improvement that the additional reinsurance protection prompted on PMIG’s balance sheet, as well as on-going strategies to improve results, the ratings have been removed from under review with negative implications.

Still, the negative outlooks consider the execution risk associated with PMIG’s additional initiatives surrounding its balance sheet strength. AM Best’s expectation is for continued improvement in the group’s reserving trends, policyholders’ surplus growth and overall levels of risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio (BCAR) over the near term. Management has significantly refined its underwriting appetite and exited particular lines of business and geographic locations. These decisions are the result of management’s focus on only underwriting healthcare verticals that support sustainable profitability and align with the company’s underwriting expertise. In conjunction with its reduced net risk exposure, this is expected to drive improved results. Additionally, PMIG is emphasizing conservatism in its total reserves to ensure reserve adequacy and continue its pursuit of strategies aimed at further strengthening its capital position. However, in the absence of material improvement in PMIG’s key balance sheet strength metrics, the ratings would likely be downgraded.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241030121401/en/